<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03324828</url>
  </required_header>
  <id_info>
    <org_study_id>SONRISA</org_study_id>
    <nct_id>NCT03324828</nct_id>
  </id_info>
  <brief_title>Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)</brief_title>
  <acronym>SONRISA</acronym>
  <official_title>Double-blind Randomized Clinical Trial to Compare Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital San Carlos, Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital San Carlos, Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the change in preoperative anxiety, baseline (M1) and pre-induction
      anxiety levels (M3), as shown by children undergoing MAS determined by the m-YPAS scale in
      the different APO management groups.Patients will be allocated in one of this four groups:
      hydroxyzine+clown; hydroxyzine alone, clowns alone or nothing
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Clowns: outcomes assesor Hidroxicine: participant, care provider, investigator and outcomes assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>m-YPAS</measure>
    <time_frame>Anxiety in the operation room (average 60 minutes from the begining of the study)</time_frame>
    <description>Yale Preoperative Anxiety Scale (mYPAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>m-YPAS</measure>
    <time_frame>Anxiety when the patient arrives at operation room (average 45 minutes from the begining of the study)</time_frame>
    <description>Yale Preoperative Anxiety Scale (mYPAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol level (blood)</measure>
    <time_frame>Just before starting surgery (average 75 minutes from the begining of the study)</time_frame>
    <description>cortisol blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol level (salive)</measure>
    <time_frame>when the patient arrives at operation room(average 45 minutes from the begining of the study)</time_frame>
    <description>cortisol blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia induction</measure>
    <time_frame>Just before starting surgery (average 75 minutes from the begining of the study)</time_frame>
    <description>Anesthesia induction according to the checklist</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">188</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Hydroxyzine+no clowns</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive hydroxyzine solution and no additional intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxyzine+clowns</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive hydroxyzine solution and clowns intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo+clowns</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive placebo solution and clowns intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo+no clowns</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive placebo solution and no additional intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyzine</intervention_name>
    <description>Hydroxyzine solution</description>
    <arm_group_label>Hydroxyzine+no clowns</arm_group_label>
    <arm_group_label>Hydroxyzine+clowns</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clowns intervention</intervention_name>
    <description>Clowns intervention</description>
    <arm_group_label>Hydroxyzine+clowns</arm_group_label>
    <arm_group_label>Placebo+clowns</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children between 2 and 16 years old

          -  Patients with programmed major ambulatory surgery.

          -  Assessment of anesthetic risk ASA I-II.

          -  Informed consent signed by their legal authorized representatives.

          -  No antihistaminic allergies.

          -  Assent signed by children between 12 and 16 years old.

        Exclusion Criteria:

          -  Patients with previous surgeries.

          -  Anesthetic risk ASA more than II.

          -  Patients with hypersensitivity to the active substance, to any of the excipients, to
             cetirizine, to other piperazine derivatives, to aminophylline or etilenamida

          -  Patients with porphyria

          -  Patients with known QT prolongation, either congenital or acquired

          -  Patients with known risk factors for QT prolongation including a pre-existing
             cardiovascular disease, previous electrolyte imbalances, family history of sudden
             cardiac death, significant bradycardia and concomitant use of drugs with potential
             known to produce QT prolongation and / or induce Torsades de Pointes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Esther Aleo Lujan, MD</last_name>
    <phone>+34 913303555</phone>
    <email>esther.aleo@salud.madrid.org</email>
  </overall_contact>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital San Carlos, Madrid</investigator_affiliation>
    <investigator_full_name>Esther Aleo Lujan</investigator_full_name>
    <investigator_title>Esther Aleo Lujan, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>anxiety</keyword>
  <keyword>surgery</keyword>
  <keyword>clown</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyzine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

